What is Repligen's stock-based comp?

Repligen (RGEN) reported stock-based comp of $8.32M in Q1 2026.

How has Repligen's stock-based comp changed year-over-year?

Repligen's stock-based comp increased by 14.4% year-over-year, from $7.27M to $8.32M.

What is the long-term trend for Repligen's stock-based comp?

Over 4 years (2021 to 2025), Repligen's stock-based comp has grown at a 4.3% compound annual growth rate (CAGR), from $27.5M to $32.61M.

What does stock-based comp mean?

Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.

Repligen RGEN Stock-Based Comp

Stock-Based Comp at other companies

TEC

Bio-TechneTECH

$10.5M-7.9%

RevvityRVTY

$8.72M+12.7%

Thermo Fisher ScientificTMO

$83M+10.7%

DanaherDHR

$58M-4.9%

Agilent TechnologiesA

$32M+6.7%

Charles River LaboratoriesCRL

$22.38M+70.4%

Other financials

Income statement

See full

Revenue$194.3M+14.8%

Gross profit$108.3M+18.5%

Operating income$15.9M+142%

Net income$8.3M+42.9%

EPS (diluted)$0.15+50.0%

Balance sheet

See full

Cash & equivalents$582.7M-16.4%

Total debt$687.6M+346%

Total equity$2.1B+6.0%

Total assets$2.9B+2.8%

Cash flow

See full

Operating cash flow$28.3M+88.6%

CapEx$4.7M+32.2%

Free cash flow$23.6M+106%

Valuation

See full

Market cap$7.45B-7.1%

Enterprise value$7.55B+2.1%

P/E144.9×—

P/S10.1×-0.1×

Profitability

See full

Gross margin49.5%+2.7pp

Operating margin1.5%-14.0pp

Net margin17.1%-3.7pp

FCF margin21.2%+6.1pp

Returns & leverage

See full

Return on equity2.5%+1.9pp

Debt / equity0.3×+0.2×

Current ratio9.2×+2.4×

Where this comes from

Reported directly by Repligen in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensation.

The official record: Repligen’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Repligen's stock-based comp.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Repligen's stock-based comp?: Repligen (RGEN) reported stock-based comp of $8.32M in Q1 2026.
How has Repligen's stock-based comp changed year-over-year?: Repligen's stock-based comp increased by 14.4% year-over-year, from $7.27M to $8.32M.
What is the long-term trend for Repligen's stock-based comp?: Over 4 years (2021 to 2025), Repligen's stock-based comp has grown at a 4.3% compound annual growth rate (CAGR), from $27.5M to $32.61M.
What does stock-based comp mean?: Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.